Kazia Therapeutics KZIA
NASDAQ KZIA
$8.11 -0.07 (-0.84%)
As of: Oct 22, 2026 · 9:38 AM EDT

Kazia Therapeutics (KZIA) EBITDA Margin (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) posted EBITDA Margin of -51223.81% for the year ended Jun 30, 2025, down 50132.82 percentage points from -1090.99% a year earlier.

Analysis

Kazia Therapeutics (KZIA) EBITDA Margin (2009 - 2013) Analysis & Trends

Since the year ended Jun 30, 2009, Kazia Therapeutics has reported EBITDA Margin for 13 years.

  • Annual EBITDA Margin shows a four-year change of -51173.50 percentage points (years ended Jun 2021 to Jun 2025).
  • The figure for the year ended Jun 30, 2025 stands as the lowest annual EBITDA Margin in data going back to the year ended Jun 30, 2009.
  • Business Quant data shows KZIA's EBITDA Margin at -1090.99% in the year ended Jun 30, 2024 and -50.31% in the year ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,152.37 Bn 1,120.96 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 628.86 Bn 547.39 Bn 17.26 Bn 35.95%
3 AbbVie 500.37 Bn 473.48 Bn 12.70 Bn 49.01%
4 Merck 374.01 Bn 328.39 Bn 12.21 Bn 6.02%
5 Novartis Ag 300.56 Bn 264.55 Bn 11.24 Bn -
6 Astrazeneca 263.92 Bn 237.60 Bn 12.86 Bn 33.11%
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn 46.01%
8 Gilead Sciences 192.21 Bn 166.40 Bn 6.22 Bn -124.26%
9 Pfizer 171.20 Bn 117.84 Bn 10.94 Bn 39.16%
10 Kazia Therapeutics 592,658.47 -51.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 30, 2013 -589.65%
Dec 31, 2012 -2,036.19%
Dec 31, 2009 103.46%
API Access

Kazia Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY